North China Pharmaceutical Company.Ltd (SHA:600812)

Market Cap	10.89B
Revenue (ttm)	9.89B
Net Income (ttm)	166.33M
Shares Out	1.72B
EPS (ttm)	0.10
PE Ratio	65.90
Forward PE	57.73
Dividend	0.03 (0.49%)
Ex-Dividend Date	n/a

Volume	45,138,176
Average Volume	21,291,912
Open	6.20
Previous Close	6.35
Day's Range	6.10 - 6.47
52-Week Range	4.03 - 6.91
Beta	0.63
RSI	60.85
Earnings Date	Aug 14, 2025

About SHA:600812

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China. The company primarily offers anti-infective drugs; biotechnology drugs; cardiovascular cerebrovascular; immunomodulators; and vitamins and health products. It also provides chemical pharmaceuticals, biological agricultural and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is based in Shijiazhuang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 10,088
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600812

Financial Performance

In 2024, SHA:600812's revenue was 9.87 billion, a decrease of -2.48% compared to the previous year's 10.12 billion. Earnings were 126.99 million, an increase of 2496.79%.